UCSI University
7
1
1
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Flexy3 Supplementation and Joint Health
Role: collaborator
"Perfect Heartio" Drink and Cardiovascular Health
Role: collaborator
Eczeva Supplementation and Skin Health
Role: collaborator
Efficacy of Twinkle Eyez Supplementation in Improving Ocular Health and Immunity
Role: collaborator
Effect of Fermented Soybean (FSB) Supplementation on Gas-troesophageal Reflux Disease (GERD)
Role: collaborator
Factors Associated With Infant Circadian Rhythm, Growth, and Temperament
Role: lead
Impact of a Pharmaceutical Care Model in the Management of Chronic Myeloid Leukemia Patients
Role: lead
All 7 trials loaded